MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

MR Radiation Oncology Suite Provides Consistent Patient Positioning, Effectively Characterizes Cancer

By MedImaging International staff writers
Posted on 20 Feb 2014
Print article
Image: GE Healthcare’s MR radiation oncology suite (Photo courtesy of GE Healthcare).
Image: GE Healthcare’s MR radiation oncology suite (Photo courtesy of GE Healthcare).
A magnetic resonance imaging (MRI) radiation oncology suite provides the tools designed to help better target and treat tumors through consistent patient positioning.

When combined with the advanced capabilities of wide-bore magnetic resonance imaging, GE Healthcare’s (Chalfont St. Giles UK) MR radiation oncology suite may help clinicians more effectively characterize disease, plan radiotherapy options, target tumors, preserve healthy tissue, and assess response to therapy. Moreover, it also helps minimize potential registration errors between MR and computed tomography (CT) within treatment plans.

GE Healthcare designed patient-positioning packages for a broad range of tumor treatments, including brain, head, and neck, prostate and gynecologic. These packages provide the freedom to purchase only what is needed now, providing the flexibility required to meet budgetary and clinical requirements.

Features of the suite include one-shot coverage, in that the user can visualize liver anatomy with a large detector, 41 x 41 cm; a three-step liver embolization guidance to improve patient outcomes, and an unmounted gantry providing excellent patient access and imaging positioning freedom.

Related Links:

GE Healthcare 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Illuminator
Trimline Basic
Ultrasound Software
UltraExtend NX
Ultrasound System
Acclarix AX9

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more